Create a narrative

Genmab Community

CPSE:GMAB Community

1 Narratives written by author
0 Comments on narratives written by author
87 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 17 Analysts

Late-Stage Investments In EPKINLY, Rina-S, And Acasunlimab Will Expand Market Potential

Key Takeaways Strategic investments in late-stage programs and expansions into new markets are poised to drive significant revenue and market reach growth for Genmab. Focused allocation of R&D funding enhances long-term value, impacting earnings by optimizing resource deployment for maximum return.

DKK 2.02k

FV

31.7% undervalued

15.21%

Revenue growth p.a.

2

0

46

about 5 hours ago